Valuation: SciSparc Ltd.

Market Cap 6L 6L 5L 5L 9L 6.01Cr 9L 62.87L 24.89L 3.15Cr 23.77L 23.26L 9.93Cr P/E 2024
-0.33x
P/E 2025 -0.12x
Enterprise Value -35.92L -32.07L -29.63L -26.85L -50.24L -34Cr -51.07L -3.57Cr -1.41Cr -18Cr -1.35Cr -1.32Cr -56Cr EV / Sales 2024
-5,51,308x
EV / Sales 2025 2,89,759x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day-9.17%
1 week-35.88%
Current month-76.91%
1 month-79.78%
3 months-79.55%
6 months-83.71%
Current year-91.09%
1 week 1.07
Extreme 1.07
1.72
1 month 1.07
Extreme 1.07
5.33
Current year 1.07
Extreme 1.07
15.79
1 year 1.07
Extreme 1.07
35.47
3 years 1.07
Extreme 1.07
2,687.56
5 years 1.07
Extreme 1.07
40,049.18
10 years 0.49
Extreme 0.4914
41,769.08
Manager TitleAgeSince
Chief Executive Officer 39 10/01/2022
Chief Executive Officer 62 21/08/2020
Chief Tech/Sci/R&D Officer 56 08/02/2016
Director TitleAgeSince
Chairman 62 10/01/2022
Chairman 79 21/09/2025
Director/Board Member 50 21/08/2020
Change 5-day change 1-year change 3-year change Capi.($)
-9.17%-35.88%-96.99%-99.88% 6L
-2.54%+1.31%+54.27%+114.96% 1,13500Cr
-1.42%+3.23%+38.56%+74.44% 64TCr
+0.16%+0.08%+25.29%+95.23% 50TCr
-0.31%+3.09%+44.14%+64.80% 38TCr
-1.34%-0.47%+66.04%+41.00% 36TCr
-0.68%+2.65%+22.98%+50.39% 29TCr
-1.20%+3.04%+2.33%+22.86% 27TCr
-1.79%+1.57%+50.56%+59.08% 24TCr
-0.73%-0.10%+29.02%+99.67% 19TCr
Average -1.90%-1.64%+23.62%+52.25% 40.04TCr
Weighted average by Cap. -1.35%+2.66%+41.02%+79.75%

Financials

2024 2025
Net sales 1.31 1.17 1.08 0.98 1.83 123.98 1.86 12.97 5.13 64.96 4.9 4.8 204.79 0.86 0.76 0.71 0.64 1.2 81.26 1.22 8.5 3.36 42.57 3.21 3.14 134.23
Net income -62.84L -56.12L -51.84L -46.98L -87.89L -60Cr -89.35L -6.24Cr -2.47Cr -31Cr -2.36Cr -2.31Cr -99Cr -1.22Cr -1.09Cr -1Cr -91.05L -1.7Cr -115.61Cr -1.73Cr -12Cr -4.79Cr -61Cr -4.57Cr -4.47Cr -190.97Cr
Net Debt -20.11L -17.96L -16.59L -15.03L -28.13L -19Cr -28.59L -2Cr -79.04L -10Cr -75.47L -73.87L -32Cr -42.25L -37.73L -34.85L -31.59L -59.09L -40Cr -60.07L -4.19Cr -1.66Cr -21Cr -1.59Cr -1.55Cr -66Cr
Projected Income Statement - Annual - SciSparc Ltd.
Logo SciSparc Ltd.
Scisparc Ltd, formerly Therapix Biosciences Ltd, is an Israel-based pharmaceutical company committed to creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The Company is engaged in drug development programs based on repurposing cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), obstructive sleep apnea (OSA) and pain; THX-130 for the treatment of mild cognitive impairment (MCI) and traumatic brain injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Employees
3
Date Price Change Volume
23/26/23 $1.090 -9.17% 60,04,406
22/26/22 $1.200 -10.45% 4,61,950
21/26/21 $1.340 +0.75% 53,467
20/26/20 $1.330 -5.00% 1,02,786
19/26/19 $1.400 -17.65% 2,20,194

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - SciSparc Ltd.
  1. Stock Market
  2. Stocks
  3. SPRC Stock